CAJ | 학술논문

目的:观察糜蛋白酶溶液联合氨溴索雾化吸入对老慢支急发患者的疗效.方法:在综合治疗的基础上,治疗组给予糜蛋白酶联合氨溴索雾化吸入,对照组给予氨溴索雾化吸入.结果:对照组总有效率为75.0%,治疗组总有效率为97.5%,治疗组明显优于对照组(P<0.05).结论:雾化吸入治疗老慢支急发作,糜蛋白酶联合氨溴索雾化吸入优于单纯氨溴索治疗.
목적:관찰미단백매용액연합안추색무화흡입대로만지급발환자적료효.방법:재종합치료적기출상,치료조급여미단백매연합안추색무화흡입,대조조급여안추색무화흡입.결과:대조조총유효솔위75.0%,치료조총유효솔위97.5%,치료조명현우우대조조(P<0.05).결론:무화흡입치료로만지급발작,미단백매연합안추색무화흡입우우단순안추색치료.
Objective: To observe the efficacy of chymotrypsin combined with ambroxol inhalation therapy in 80 patients with acute exacerbations of chronic bronchitis. Methods:The patients admitted to the emergency department were randomly assigned to either a treatment group or a control group, in which chymotrypsin in combination with ambroxol inhalation or only atomizing ambroxol inhalation (hydrochloride) were respectively given on the basis of the comprehensive treatment. Results:The total efficiency was 97.5%in the treatment group and 75%in the control group. The between-group difference is statistically significant (P<0.05). Conclusion:Chymotrypsin in combination with ambroxol inhalation can significantly improve the clinical efficacy in patients with acute exacerbations of chronic bronchitis.